查看购物车
  • Traditional Chinese
  • English
2031年北美医疗外骨骼市场预测—区域分析—按组件、类型、肢体、应用、移动性和最终用户
市场调查报告书
商品编码
1715171

2031年北美医疗外骨骼市场预测—区域分析—按组件、类型、肢体、应用、移动性和最终用户

North America Medical Exoskeleton Market Forecast to 2031 - Regional Analysis - by Component, Type, Extremity, Application, Mobility, and End Users
出版日期: | 出版商: The Insight Partners | 英文 102 Pages | 订单完成后即时交付

价格

2023年北美医疗外骨骼市场价值为1.593亿美元，预计到2031年将达到14.0025亿美元；预计2023年至2031年的复合年增长率为31.2%。

策略性措施不断增加推动北美医疗外骨市场发展

在医疗外骨骼市场运营的大小公司采用各种策略来提高收入，例如地理扩张、新产品发布和技术进步。以下提到了医疗外骨骼市场的一些最新发展； 2022 年 7 月，Ekso Bionics Holdings Inc. 获得美国食品药物管理局 (FDA) 的批准，向多发性硬化症患者销售其 EksoNR 机器人外骨骼。它于 2016 年获批用于中风和脊髓损伤 (SCI) 康復，并于 2020 年获得脑损伤復健治疗许可。它还获得了 CE 认证，并在欧洲上市。

三星电子的辅助机器人「GEMS Hip」获得了美国 FDA 的认证，这是一款穿戴式设备，可作为行动不便用户的外骨骼，使用主动辅助演算法来改善步态和肌肉运动。 2021年12月，德国Bionic公司推出第五代Cray X外骨骼。第五代 Cray X 彰显了其在快速成长的国际外骨骼市场的技术领先地位。该公司的创新正在为全球更多个人和企业在更广泛的用例和行业中受益铺平道路。 2021 年 11 月，奥托博克收购了位于湾区的外骨骼新创公司 SuitX。 SuitX 是加州大学柏克莱分校机器人与人类工程实验室的衍生公司。两家公司实际上都属于同一类别，生产用于两个不同目的（工作辅助和医疗保健）的机器人外骨骼。 2021年5月，Roam Robotics推出了智慧膝关节矫正器“Ascend”，可帮助穿戴者减轻膝关节疼痛并恢復活动能力。它能感知身体的运动，根据配戴者的需求自动调整，并在适当的时刻为目标肌肉群提供精确的支撑。它是经过 FDA 批准的註册 I 类设备，可直接购买或透过私人和医疗保险购买，从根本上扩大了公众对穿戴式机器人设备的可及性。因此，市场参与者积极参与产品发布、扩张、合作和併购，推动了医疗外骨骼市场的成长。

北美医疗外骨骼市场概况

市场参与者正在获得美国的产品批准，以增强外骨骼业务。例如，2022 年 7 月，Ekso Bionics Holdings Inc. 获得美国食品药物管理局 (FDA) 的行销批准，其 EksoNR 机器人外骨骼可用于治疗多发性硬化症患者。因此，美国医疗保健产业各医疗器材巨头的不断发展将在未来几年进一步推动该国医疗外骨骼市场的发展。

北美医疗外骨骼市场收入及预测（2031年）（百万美元）

北美医疗外骨市场细分

北美医疗外骨骼市场分为组件、类型、肢体、应用、移动性、最终用户和国家。

根据组成部分，北美医疗外骨骼市场分为硬体和软体。 2023 年，硬体部分占据了北美医疗外骨骼市场的较大份额。

从类型来看，北美医疗外骨骼市场分为动力外骨骼和被动外骨骼。 2023 年，动力外骨骼领域占据了北美医疗外骨骼市场的较大份额。

根据肢体，北美医疗外骨骼市场分为下半身外骨骼、上半身外骨骼和全身外骨骼。 2023 年，下肢外骨骼领域占据北美医疗外骨骼市场的最大份额。

根据应用，北美医疗外骨骼市场分为脊髓损伤、多发性硬化症、中风、脑性麻痹、巴金森氏症等。 2023 年，脊髓损伤领域占据北美医疗外骨骼市场的最大份额。

就移动性而言，北美医疗外骨骼市场分为移动外骨骼和固定外骨骼。 2023 年，动力外骨骼领域占据了北美医疗外骨骼市场的较大份额。

根据最终用户，北美医疗外骨骼市场分为復健中心、物理治疗中心、长期照护中心、家庭护理机构等。 2023 年，復健中心部门占据北美医疗外骨骼市场的最大份额。

根据国家/地区，北美医疗外骨骼市场分为美国、加拿大和墨西哥。 2023 年，美国占据北美医疗外骨骼市场的最大份额。

比奥尼克； B-Temia 公司； Cyber​​dyne公司； Ekso Bionics Holdings Inc； ExoAtlet；霍科马股份公司； Lifeward 公司； Myomo 公司；和 Rex Bionics Ltd. 是北美医疗外骨骼市场的一些领先公司。

目录

第一章：简介

第二章：执行摘要

  • 关键见解

第三章：研究方法

  • 二次研究
  • 初步研究
    • 假设表述：
    • 宏观经济因素分析：
    • 显影基数：
    • 数据三角测量：
    • 国家级资料：

第四章：北美医疗外骨骼市场-关键市场动态

  • 市场驱动因素：
    • 策略倡议不断增加
    • 中风和肌肉骨骼疾病发生率不断上升
    • 老年人口寿命延长
  • 市场限制
    • 产品成本高和监管问题
  • 市场机会
    • 脊髓损伤盛行率不断上升
  • 未来趋势
    • 科技进步不断加快，投资不断增加
  • 驱动因素和限制因素的影响：

第五章：医疗外骨骼市场-北美分析

  • 2021-2031年北美医疗外骨骼市场收入
  • 北美医疗外骨骼市场预测分析

第六章：北美医疗外骨骼市场分析-按组件

  • 硬体
  • 软体

第七章：北美医疗外骨骼市场分析-按类型

  • 动力外骨骼
  • 被动外骨骼

第 8 章：北美医疗外骨骼市场分析 - Extremity

  • 下肢外骨骼
  • 上身外骨骼
  • 全身外骨骼

第九章：北美医疗外骨骼市场分析-按应用

  • 脊髓损伤
  • 多发性硬化症
  • 中风
  • 脑性麻痹
  • 帕金森氏症
  • 其他的

第 10 章：北美医疗外骨骼市场分析 - 按移动性

  • 移动外骨骼
  • 固定式外骨骼

第 11 章：北美医疗外骨骼市场分析 - 按最终用户

  • 復健中心
  • 物理治疗中心
  • 长期照护中心
  • 家庭护理设置
  • 其他的

第 12 章：北美医疗外骨骼市场-国家分析

  • 美国
  • 加拿大
  • 墨西哥

第 13 章：医疗外骨骼市场-产业格局

  • 概述
  • 医疗外骨骼市场的成长策略
  • 有机成长策略
    • 概述
  • 无机成长策略
    • 概述

第 14 章：公司简介

  • Ekso Bionics Holdings Inc
  • Lifeward, Inc
  • ExoAtlet
  • Cyberdyne Inc
  • BIONIK
  • B-Temia Inc
  • Hocoma AG
  • Myomo Inc
  • Rex Bionics Ltd.

第 15 章：附录

Product Code: BMIRE00031137

The North America medical exoskeleton market was valued at US$ 159.30 million in 2023 and is expected to reach US$ 1,400.25 million by 2031; it is estimated to register a CAGR of 31.2% from 2023 to 2031.

Rising Number of Strategic Initiatives Fuels North America Medical Exoskeleton Market

Small and big companies operating in the medical exoskeleton market adopt various strategies such as geographic expansion, new product launches, and technological advancements to boost their revenues. A few recent developments in the medical exoskeleton market are mentioned below; In July 2022, Ekso Bionics Holdings Inc. received approval from the US Food and Drug Administration (FDA) to market its EksoNR robotic exoskeleton for patients suffering from multiple sclerosis. It was cleared for stroke and spinal cord injury (SCI) rehabilitation in 2016 and acquired brain injury in 2020. It has also received CE certification and is available in Europe.

Samsung Electronics has received the US FDA for its assistive robot "GEMS Hip," a wearable device that acts as an exoskeleton for users with mobility issues using an active assist algorithm to improve gait and muscle movement. In December 2021, German Bionic launched the fifth generation of the Cray X exoskeleton. The fifth-generation Cray X underscores technology leadership in the massively growing international exoskeleton market. The company's innovations are paving the way for more people and businesses worldwide to benefit across a wider range of use cases and industries. In November 2021, Ottobock acquired Bay Area-based exoskeleton startup SuitX. SuitX is a spinout of UC Berkeley's Robotics and Human Engineering Lab. Both companies effectively operate in the same category, producing robotic exoskeletons designed for two distinct purposes-work assistance and healthcare. In May 2021, Roam Robotics launched "Ascend," a smart knee orthosis that helps wearers reduce knee pain and regain mobility. It senses the body's movement, automatically adjusts to the wearer's needs, and provides precise support at the right moment for target muscle groups. It is a registered Class I device with FDA approval available for purchase directly and through private and Medicare insurance, radically expanding public accessibility to wearable robotic devices. Therefore, the active participation of market players in product launches, expansions, partnerships, and mergers & acquisitions boosts the growth of the medical exoskeleton market.

North America Medical Exoskeleton Market Overview

Market players are receiving product approvals in the US to enhance the exoskeleton business. For instance, in July 2022, Ekso Bionics Holdings Inc. received marketing approval from the US Food and Drug Administration for its EksoNR robotic exoskeleton to use in patients with multiple sclerosis. Thus, the growing developments by various medical device giants in the US healthcare industry will further boost the market for medical exoskeletons in the country in the upcoming years.

North America Medical Exoskeleton Market Revenue and Forecast to 2031 (US$ Million)

North America Medical Exoskeleton Market Segmentation

The North America medical exoskeleton market is categorized into component, type, extremity, application, mobility, end users, and country.

By component, the North America medical exoskeleton market is segmented into hardware and software. The hardware segment held a larger share of the North America medical exoskeleton market share in 2023.

In terms of type, the North America medical exoskeleton market is segmented into powered exoskeleton and passive exoskeleton. The powered exoskeleton segment held a larger share of the North America medical exoskeleton market share in 2023.

Based on extremity, the North America medical exoskeleton market is segmented into lower body exoskeleton, upper body exoskeleton, and full body exoskeleton. The lower body exoskeleton segment held the largest share of the North America medical exoskeleton market share in 2023.

By application, the North America medical exoskeleton market is segmented into spinal cord injury, multiple sclerosis, stroke, cerebral palsy, Parkinson's Disease, and others. The spinal cord injury segment held the largest share of the North America medical exoskeleton market share in 2023.

In terms of mobility, the North America medical exoskeleton market is segmented into mobile exoskeleton and stationary exoskeleton. The powered exoskeleton segment held a larger share of the North America medical exoskeleton market share in 2023.

By end users, the North America medical exoskeleton market is segmented into rehabilitation centers, physiotherapy centers, long term care centers, homecare settings, and others. The rehabilitation centers segment held the largest share of the North America medical exoskeleton market share in 2023.

Based on country, the North America medical exoskeleton market is segmented into the US, Canada, and Mexico. The US segment held the largest share of North America medical exoskeleton market in 2023.

BIONIK; B-Temia Inc; Cyberdyne Inc; Ekso Bionics Holdings Inc; ExoAtlet; Hocoma AG; Lifeward, Inc; Myomo Inc; and Rex Bionics Ltd. are some of the leading companies operating in the North America medical exoskeleton market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. North America Medical Exoskeleton Market - Key Market Dynamics

  • 4.1 Market Drivers:
    • 4.1.1 Rising Number of Strategic Initiatives
    • 4.1.2 Growing Incidence of Stroke and Musculoskeletal
    • 4.1.3 Increasing Longevity of Aging Population
  • 4.2 Market Restraints
    • 4.2.1 High Cost of Product and Regulatory Concerns
  • 4.3 Market Opportunities
    • 4.3.1 Increasing Prevalence of SCI
  • 4.4 Future Trends
    • 4.4.1 Increasing Technological Advancements and Rising Investments
  • 4.5 Impact of Drivers and Restraints:

5. Medical Exoskeleton Market - North America Analysis

  • 5.1 North America Medical Exoskeleton Market Revenue (US$ Million), 2021-2031
  • 5.2 North America Medical Exoskeleton Market Forecast Analysis

6. North America Medical Exoskeleton Market Analysis - by Component

  • 6.1 Hardware
    • 6.1.1 Overview
    • 6.1.2 Hardware: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.2 Software
    • 6.2.1 Overview
    • 6.2.2 Software: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)

7. North America Medical Exoskeleton Market Analysis - by Type

  • 7.1 Powered Exoskeleton
    • 7.1.1 Overview
    • 7.1.2 Powered Exoskeleton: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Passive Exoskeleton
    • 7.2.1 Overview
    • 7.2.2 Passive Exoskeleton: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)

8. North America Medical Exoskeleton Market Analysis - by Extremity

  • 8.1 Lower Body Exoskeleton
    • 8.1.1 Overview
    • 8.1.2 Lower Body Exoskeleton: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 Upper Body Exoskeleton
    • 8.2.1 Overview
    • 8.2.2 Upper Body Exoskeleton: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Full Body Exoskeleton
    • 8.3.1 Overview
    • 8.3.2 Full Body Exoskeleton: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)

9. North America Medical Exoskeleton Market Analysis - by Application

  • 9.1 Spinal Cord Injury
    • 9.1.1 Overview
    • 9.1.2 Spinal Cord Injury: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.2 Multiple Sclerosis
    • 9.2.1 Overview
    • 9.2.2 Multiple Sclerosis: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.3 Stroke
    • 9.3.1 Overview
    • 9.3.2 Stroke: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.4 Cerebral Palsy
    • 9.4.1 Overview
    • 9.4.2 Cerebral Palsy: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.5 Parkinson's Diseases
    • 9.5.1 Overview
    • 9.5.2 Parkinson's Diseases: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)

10. North America Medical Exoskeleton Market Analysis - by Mobility

  • 10.1 Mobile Exoskeleton
    • 10.1.1 Overview
    • 10.1.2 Mobile Exoskeleton: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.2 Stationary Exoskeleton
    • 10.2.1 Overview
    • 10.2.2 Stationary Exoskeleton: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)

11. North America Medical Exoskeleton Market Analysis - by End Users

  • 11.1 Rehabilitation Centers
    • 11.1.1 Overview
    • 11.1.2 Rehabilitation Centers: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.2 Physiotherapy Centers
    • 11.2.1 Overview
    • 11.2.2 Physiotherapy Centers: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.3 Long Term Care Centers
    • 11.3.1 Overview
    • 11.3.2 Long Term Care Centers: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.4 Homecare Settings
    • 11.4.1 Overview
    • 11.4.2 Homecare Settings: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.5 Others
    • 11.5.1 Overview
    • 11.5.2 Others: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)

12. North America Medical Exoskeleton Market - Country Analysis

  • 12.1 North America Medical Exoskeleton Market
    • 12.1.1 North America Medical Exoskeleton Market - Revenue and Forecast Analysis - by Country
      • 12.1.1.1 United States: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.1.1 United States: Medical Exoskeleton Market Breakdown, by Component
        • 12.1.1.1.1.1 United States: Medical Exoskeleton Market Breakdown, by Hardware
        • 12.1.1.1.1.1.1 United States: Medical Exoskeleton Market Breakdown, by Actuators
        • 12.1.1.1.2 United States: Medical Exoskeleton Market Breakdown, by Type
        • 12.1.1.1.3 United States: Medical Exoskeleton Market Breakdown, by Extremity
        • 12.1.1.1.4 United States: Medical Exoskeleton Market Breakdown, by Application
        • 12.1.1.1.5 United States: Medical Exoskeleton Market Breakdown, by Mobility
        • 12.1.1.1.6 United States: Medical Exoskeleton Market Breakdown, by End Users
      • 12.1.1.2 Canada: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.2.1 Canada: Medical Exoskeleton Market Breakdown, by Component
        • 12.1.1.2.1.1 Canada: Medical Exoskeleton Market Breakdown, by Hardware
        • 12.1.1.2.1.1.1 Canada: Medical Exoskeleton Market Breakdown, by Actuators
        • 12.1.1.2.2 Canada: Medical Exoskeleton Market Breakdown, by Type
        • 12.1.1.2.3 Canada: Medical Exoskeleton Market Breakdown, by Extremity
        • 12.1.1.2.4 Canada: Medical Exoskeleton Market Breakdown, by Application
        • 12.1.1.2.5 Canada: Medical Exoskeleton Market Breakdown, by Mobility
        • 12.1.1.2.6 Canada: Medical Exoskeleton Market Breakdown, by End Users
      • 12.1.1.3 Mexico: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.3.1 Mexico: Medical Exoskeleton Market Breakdown, by Component
        • 12.1.1.3.1.1 Mexico: Medical Exoskeleton Market Breakdown, by Hardware
        • 12.1.1.3.1.1.1 Mexico: Medical Exoskeleton Market Breakdown, by Actuators
        • 12.1.1.3.2 Mexico: Medical Exoskeleton Market Breakdown, by Type
        • 12.1.1.3.3 Mexico: Medical Exoskeleton Market Breakdown, by Extremity
        • 12.1.1.3.4 Mexico: Medical Exoskeleton Market Breakdown, by Application
        • 12.1.1.3.5 Mexico: Medical Exoskeleton Market Breakdown, by Mobility
        • 12.1.1.3.6 Mexico: Medical Exoskeleton Market Breakdown, by End Users

13. Medical Exoskeleton Market - Industry Landscape

  • 13.1 Overview
  • 13.2 Growth Strategies in Medical Exoskeleton Market
  • 13.3 Organic Growth Strategies
    • 13.3.1 Overview
  • 13.4 Inorganic Growth Strategies
    • 13.4.1 Overview

14. Company Profiles

  • 14.1 Ekso Bionics Holdings Inc
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Lifeward, Inc
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 ExoAtlet
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 Cyberdyne Inc
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 BIONIK
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 B-Temia Inc
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 Hocoma AG
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments
  • 14.8 Myomo Inc
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Products and Services
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments
  • 14.9 Rex Bionics Ltd.
    • 14.9.1 Key Facts
    • 14.9.2 Business Description
    • 14.9.3 Products and Services
    • 14.9.4 Financial Overview
    • 14.9.5 SWOT Analysis
    • 14.9.6 Key Developments

15. Appendix

  • 15.1 About Us
  • 15.2 Glossary of Terms

List Of Tables

  • Table 1. North America Medical Exoskeleton Market Segmentation
  • Table 2. North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Table 3. North America Medical Exoskeleton Market, by Hardware - Revenue and Forecast to 2031 (USD Million)
  • Table 4. North America Medical Exoskeleton Market, by Actuators - Revenue and Forecast to 2031 (USD Million)
  • Table 5. United States: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million) - by Component
  • Table 6. United States: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million) - by Hardware
  • Table 7. United States: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million) - by Actuators
  • Table 8. United States: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 9. United States: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million) - by Extremity
  • Table 10. United States: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 11. United States: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million) - by Mobility
  • Table 12. United States: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million) - by End Users
  • Table 13. Canada: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million) - by Component
  • Table 14. Canada: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million) - by Hardware
  • Table 15. Canada: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million) - by Actuators
  • Table 16. Canada: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 17. Canada: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million) - by Extremity
  • Table 18. Canada: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 19. Canada: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million) - by Mobility
  • Table 20. Canada: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million) - by End Users
  • Table 21. Mexico: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million) - by Component
  • Table 22. Mexico: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million) - by Hardware
  • Table 23. Mexico: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million) - by Actuators
  • Table 24. Mexico: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 25. Mexico: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million) - by Extremity
  • Table 26. Mexico: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 27. Mexico: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million) - by Mobility
  • Table 28. Mexico: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million) - by End Users
  • Table 29. Recent Organic Growth Strategies in Medical Exoskeleton Market
  • Table 30. Recent Inorganic Growth Strategies in the Medical Exoskeleton Market
  • Table 31. Glossary of Terms, Medical Exoskeleton Market

List Of Figures

  • Figure 1. North America Medical Exoskeleton Market Segmentation, by Country
  • Figure 2. North America Medical Exoskeleton Market - Key Market Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. North America Medical Exoskeleton Market Revenue (US$ Million), 2021-2031
  • Figure 5. North America Medical Exoskeleton Market Share (%) - by Component (2023 and 2031)
  • Figure 6. Hardware: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. Software: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. North America Medical Exoskeleton Market Share (%) - by Type (2023 and 2031)
  • Figure 9. Powered Exoskeleton: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. Passive Exoskeleton: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. North America Medical Exoskeleton Market Share (%) - by Extremity (2023 and 2031)
  • Figure 12. Lower Body Exoskeleton: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. Upper Body Exoskeleton: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. Full Body Exoskeleton: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. North America Medical Exoskeleton Market Share (%) - by Application (2023 and 2031)
  • Figure 16. Spinal Cord Injury: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. Multiple Sclerosis: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 18. Stroke: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. Cerebral Palsy: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 20. Parkinson's Diseases: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 21. Others: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 22. North America Medical Exoskeleton Market Share (%) - by Mobility (2023 and 2031)
  • Figure 23. Mobile Exoskeleton: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 24. Stationary Exoskeleton: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 25. North America Medical Exoskeleton Market Share (%) - by End Users (2023 and 2031)
  • Figure 26. Rehabilitation Centers: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 27. Physiotherapy Centers: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 28. Long Term Care Centers: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 29. Homecare Settings: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 30. Others: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 31. North America Medical Exoskeleton Market, by Key Country - Revenue (2023) (US$ Million)
  • Figure 32. North America Medical Exoskeleton Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 33. United States: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 34. Canada: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 35. Mexico: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 36. Growth Strategies in Medical Exoskeleton Market